GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-1,245 Cr | ₹-1,066 Cr | ₹-1,049 Cr | ₹-1,805 Cr | ₹-1,655 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of GLENMARK PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-1,245 Cr |
| Mar2025 | ₹-1,066 Cr |
| Mar2024 | ₹-1,049 Cr |
| Mar2023 | ₹-1,805 Cr |
| Mar2022 | ₹-1,655 Cr |
How is Deferred Tax Assets / Liabilities of GLENMARK PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-1,245 Cr | Negative | |
| Mar2025 | ₹-1,066 Cr | Negative | |
| Mar2024 | ₹-1,049 Cr | Negative | |
| Mar2023 | ₹-1,805 Cr | Negative | |
| Mar2022 | ₹-1,655 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹73,761.4 Cr | -2.3% | 17.5% | 42.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,688.0 Cr | -1.4% | 6.3% | 7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹295,080.0 Cr | -1.8% | 20.6% | 70.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,677.0 Cr | -1.9% | 2.4% | 22.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,852.0 Cr | 0.8% | 12.6% | 12.3% | Stock Analytics | |
| CIPLA | ₹111,731.0 Cr | -2.4% | 4.4% | -8.3% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -2.3% |
17.5% |
42.3% |
| SENSEX | 1.8% |
11.1% |
-1.6% |
You may also like the below Video Courses